PL3468543T3 - Sposób zwalczania zapalenia tkanki nerwowej - Google Patents

Sposób zwalczania zapalenia tkanki nerwowej

Info

Publication number
PL3468543T3
PL3468543T3 PL17732600.6T PL17732600T PL3468543T3 PL 3468543 T3 PL3468543 T3 PL 3468543T3 PL 17732600 T PL17732600 T PL 17732600T PL 3468543 T3 PL3468543 T3 PL 3468543T3
Authority
PL
Poland
Prior art keywords
neuroinflammation
controlling
controlling neuroinflammation
Prior art date
Application number
PL17732600.6T
Other languages
English (en)
Inventor
Sofia LOPES DA SILVA
Ladislaus Maria Broersen
Robert Johan Joseph Hageman
Jan Maarten Verkuijl
Original Assignee
N.V. Nutricia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56550947&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3468543(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by N.V. Nutricia filed Critical N.V. Nutricia
Publication of PL3468543T3 publication Critical patent/PL3468543T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
PL17732600.6T 2016-06-10 2017-06-09 Sposób zwalczania zapalenia tkanki nerwowej PL3468543T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NL2016/050419 WO2017213490A1 (en) 2016-06-10 2016-06-10 Method for controlling neuroinflammation
PCT/NL2017/050380 WO2017213504A1 (en) 2016-06-10 2017-06-09 Method for controlling neuroinflammation

Publications (1)

Publication Number Publication Date
PL3468543T3 true PL3468543T3 (pl) 2024-03-18

Family

ID=56550947

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17732600.6T PL3468543T3 (pl) 2016-06-10 2017-06-09 Sposób zwalczania zapalenia tkanki nerwowej

Country Status (9)

Country Link
US (1) US10821120B2 (pl)
EP (1) EP3468543B1 (pl)
CN (1) CN109562081B (pl)
BR (1) BR112018075475A2 (pl)
ES (1) ES2966773T3 (pl)
FI (1) FI3468543T3 (pl)
PL (1) PL3468543T3 (pl)
PT (1) PT3468543T (pl)
WO (2) WO2017213490A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10842849B2 (en) 2011-02-28 2020-11-24 The Schepens Eye Research Institute, Inc. Methods for promoting neuronal outgrowth by insulin-like growth factor binding protein-like 1 (IGFBPL-1) in glaucoma or leber's optic neuropathy
US20230338305A1 (en) * 2020-05-06 2023-10-26 Regenall Limited Vitamin a for use in the treatment of traumatic brain injury
CN116139171B (zh) * 2021-11-22 2025-07-29 深圳奥萨制药有限公司 一种改善轻度脑认知功能障碍的组合物
US20240299698A1 (en) * 2022-04-29 2024-09-12 Noetix Pharma Llc Prevention and treatment of post-operative cognitive dysfunction (pocd)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7704542B2 (en) 2001-09-12 2010-04-27 Xanodyne Pharmaceuticals, Inc. Vitamin/mineral compositions with DHA
PL1800675T4 (pl) 2005-12-23 2012-02-29 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia
US20080027031A1 (en) * 2006-03-08 2008-01-31 Kinemed, Inc. Retinoids and Related Compounds for the Treatment of Neuroinflammatory Conditions, Diseases and Disorders
WO2009002148A1 (en) 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
CN101433240B (zh) * 2007-11-16 2013-01-16 光明乳业股份有限公司 一种适合孕妇和乳母食用的牛奶及其制备方法
US20120128711A1 (en) 2009-09-21 2012-05-24 Total Nutraceutical Solutions, Inc. Anti-inflammatory approach to prevention and suppression of post-traumatic stress disorder, traumatic brain injury, depression and associated disease states
WO2011093693A1 (en) * 2010-01-29 2011-08-04 N.V. Nutricia Liquid enteral nutritional composition suitable for tube feeding, minimizing lower and upper tract digestive conditions
JP2013526865A (ja) * 2010-05-13 2013-06-27 ニトロメガ コーポレーション ニトロ脂肪酸、神経保護および/または認識減退の抑制
WO2012125020A1 (en) 2011-03-14 2012-09-20 N.V. Nutricia Method for treating neurotrauma
US20120252888A1 (en) 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
WO2013066151A1 (en) 2011-10-31 2013-05-10 N.V. Nutricia Improving recognition
WO2013066152A1 (en) 2011-10-31 2013-05-10 N.V. Nutricia Method for improving executive function
EP3174544B1 (en) * 2014-07-31 2020-12-09 Universita' Degli Studi Di Cagliari Ester of a phospholipid with conjugated linoleic acid for the treatment of psychiatric disorders with neuroinflammatory and neurodegenerative basis
WO2016072842A1 (en) * 2014-11-05 2016-05-12 N.V. Nutricia Method for preventing, reducing the risk of, or treating behavioral frontotemporal dementia

Also Published As

Publication number Publication date
ES2966773T3 (es) 2024-04-24
WO2017213490A1 (en) 2017-12-14
US10821120B2 (en) 2020-11-03
CN109562081B (zh) 2022-03-18
BR112018075475A2 (pt) 2019-03-19
CN109562081A (zh) 2019-04-02
PT3468543T (pt) 2023-12-14
FI3468543T3 (fi) 2023-10-31
WO2017213504A1 (en) 2017-12-14
EP3468543B1 (en) 2023-10-04
US20190175622A1 (en) 2019-06-13
EP3468543A1 (en) 2019-04-17

Similar Documents

Publication Publication Date Title
IL263854A (en) Improved methods of differentiation
PL2997550T5 (pl) Sposób kontroli dostępu
ZA201804011B (en) Method for controlling power distribution
GB201603569D0 (en) Improved differentiation method
EP3135826A4 (en) Construction machine and method for controlling construction machine
GB201611953D0 (en) Method
GB201522297D0 (en) Method for controlling a vehicle
HUE045218T2 (hu) Visszajelzés vezérlése D2D kommunikációhoz
HRP20170990T1 (hr) Postupak za kontrolu mirisa
IL257446A (en) A method of controlling movement
GB2542067B (en) Method and system for controlling well operations
GB201515284D0 (en) Well control method
PT3468543T (pt) Método de controlo da neuroinflamação
ZA201903463B (en) Method for preparing hexadecahydropyrene
ZA201802897B (en) Preparation method for 2-mercaptobenzothiazole
GB201517062D0 (en) A first apparatus for controlling a second apparatus
GB2530019B (en) A method for controlling a communication system
IL258878B (en) method of adjustment
TWI560512B (en) System and method for controlling flash
SG10201600362SA (en) Methods For Optimising Parameters
EP3246432A4 (en) Method for treating parts
GB201415698D0 (en) Method and apparatus for controlling parasites
IL232391A0 (en) A method and system for controlling accessories
GB201604550D0 (en) Controller
GB201601042D0 (en) Method